1. Home
  2. RDCM vs ENTA Comparison

RDCM vs ENTA Comparison

Compare RDCM & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radcom Ltd.

RDCM

Radcom Ltd.

HOLD

Current Price

$13.57

Market Cap

215.2M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$15.44

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDCM
ENTA
Founded
1985
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.2M
407.5M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
RDCM
ENTA
Price
$13.57
$15.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$18.00
$20.40
AVG Volume (30 Days)
76.8K
375.0K
Earning Date
11-12-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
37.57
N/A
EPS
0.64
N/A
Revenue
$68,901,000.00
$65,324,000.00
Revenue This Year
$18.86
$0.99
Revenue Next Year
$11.39
$0.19
P/E Ratio
$20.99
N/A
Revenue Growth
17.27
N/A
52 Week Low
$9.88
$4.09
52 Week High
$15.98
$15.86

Technical Indicators

Market Signals
Indicator
RDCM
ENTA
Relative Strength Index (RSI) 55.74 68.21
Support Level $12.81 $14.07
Resistance Level $13.88 $15.28
Average True Range (ATR) 0.41 0.81
MACD 0.02 -0.03
Stochastic Oscillator 62.06 79.86

Price Performance

Historical Comparison
RDCM
ENTA

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: